Vericel VCEL Stock
Vericel Price Chart
Vericel VCEL Financial and Trading Overview
| Vericel stock price | 57.42 USD |
| Previous Close | 59.45 USD |
| Open | 59.5 USD |
| Bid | 39.62 USD x 100 |
| Ask | 52.78 USD x 100 |
| Day's Range | 56.92 - 59.5 USD |
| 52 Week Range | 28.95 - 59.75 USD |
| Volume | 826.52K USD |
| Avg. Volume | 638.06K USD |
| Market Cap | 2.93B USD |
| Beta (5Y Monthly) | 1.057 |
| PE Ratio (TTM) | 89.71875 |
| EPS (TTM) | 0.62 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 63.57 USD |
VCEL Valuation Measures
| Enterprise Value | 2.95B USD |
| Trailing P/E | 89.71875 |
| Forward P/E | 60.955414 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.038837 |
| Price/Book (mrq) | 7.6295505 |
| Enterprise Value/Revenue | 9.114 |
| Enterprise Value/EBITDA | 72.822 |
Trading Information
Vericel Stock Price History
| Beta (5Y Monthly) | 1.057 |
| 52-Week Change | 49.22% |
| S&P500 52-Week Change | 13.08% |
| 52 Week High | 59.75 USD |
| 52 Week Low | 28.95 USD |
| 50-Day Moving Average | 42.12 USD |
| 200-Day Moving Average | 39.2 USD |
VCEL Share Statistics
| Avg. Volume (3 month) | 638.06K USD |
| Avg. Daily Volume (10-Days) | 1.25M USD |
| Shares Outstanding | 51.03M |
| Float | 50.4M |
| Short Ratio | 9.63 |
| % Held by Insiders | 1.19% |
| % Held by Institutions | 110.29% |
| Shares Short | 5.36M |
| Short % of Float | 13.55% |
| Short % of Shares Outstanding | 10.51% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 10.27% |
| Operating Margin (ttm) | 8.32% |
| Gross Margin | 74.46% |
| EBITDA Margin | 12.51% |
Management Effectiveness
| Return on Assets (ttm) | 3.47% |
| Return on Equity (ttm) | 9.43% |
Income Statement
| Revenue (ttm) | 324.17M USD |
| Revenue Per Share (ttm) | 6.37 USD |
| Quarterly Revenue Growth (yoy) | 26.50% |
| Gross Profit (ttm) | 241.41M USD |
| EBITDA | 40.57M USD |
| Net Income Avi to Common (ttm) | 33.31M USD |
| Diluted EPS (ttm) | 0.64 |
| Quarterly Earnings Growth (yoy) | 179.09% |
Balance Sheet
| Total Cash (mrq) | 170.27M USD |
| Total Cash Per Share (mrq) | 3.34 USD |
| Total Debt (mrq) | 91.15M USD |
| Total Debt/Equity (mrq) | 23.73 USD |
| Current Ratio (mrq) | 5.131 |
| Book Value Per Share (mrq) | 7.526 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 65.31M USD |
| Levered Free Cash Flow (ttm) | 49.89M USD |
Profile of Vericel
| Country | United States |
| State | MA |
| City | Burlington |
| Address | 25 Blue Sky Drive |
| ZIP | 01803 |
| Phone | 617 588 5555 |
| Website | https://www.vcel.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 398 |
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.
Q&A For Vericel Stock
What is a current VCEL stock price?
Vericel VCEL stock price today per share is 57.42 USD.
How to purchase Vericel stock?
You can buy VCEL shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vericel?
The stock symbol or ticker of Vericel is VCEL.
Which industry does the Vericel company belong to?
The Vericel industry is Biotechnology.
How many shares does Vericel have in circulation?
The max supply of Vericel shares is 51.03M.
What is Vericel Price to Earnings Ratio (PE Ratio)?
Vericel PE Ratio is 92.61290000 now.
What was Vericel earnings per share over the trailing 12 months (TTM)?
Vericel EPS is 0.62 USD over the trailing 12 months.
Which sector does the Vericel company belong to?
The Vericel sector is Healthcare.
Vericel VCEL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
|
- | |||||
US Tech Composite
IXIC
US
|
25366.09 USD — |
-0.39
|
8.86B USD — | 25068.28 USD — | 25597.23 USD — | — - | 8.86B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
114.29 USD — |
-2.39
|
— — | 113.87 USD — | 116.2 USD — | — - | — — |
|
US Tech Global Market Composite
NQGM
US
|
1958.3 USD — |
-2.44
|
— — | 1956.35 USD — | 1991.22 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
31344.11 USD — |
-0.38
|
— — | 30976.16 USD — | 31629.69 USD — | — - | — — |
|
US Tech US 700 Small Cap Index
NQUS700SC
US
|
3026.97 USD — |
-1.72
|
— — | 3024.87 USD — | 3065.71 USD — | — - | — — |
|
US Tech AlphaDEX Multi Cap Growt
NQDXUSMLTCG
US
|
3774.67 USD — |
-1.37
|
— — | 3769.9 USD — | 3820.05 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1372.96 USD — |
-1.99
|
— — | 1372.67 USD — | 1394.6 USD — | — - | — — |
